Proposal to fund unapproved pharmaceutical treatments for various conditions
In a departure from normal practice, PHARMAC has entered into a provisional agreement for the funding and supply of 11 pharmaceuticals that have not been approved/registered by Medsafe, but which have been identified as important to treat conditions for which there are no registered products. Though some are already funded on Schedule 11, this proposal will provide access to funded medications for conditions such as gout, TB, helicobacter pylori, cryptosporidium infection etc. many of which disproportionally affect vulnerable people, and for some rare conditions.
Feedback due: Monday, 28 January 2013 to policy analyst, Marilyn Head email@example.com Ph 04 494 6372